Medtronic stock rises as CMS proposes favorable coverage for RDN therapy
ANALYST COVERAGE
JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win
Medtronic stock poised to rise as CMS proposes broader renal denervation coverage
An analyst from H.C. Wainwright, Robert Burns, has started coverage of Karyopharm Therapeutics (KPTI, Financial) with a Buy…
Analyst Ratings (Canada) Adentra (ADEN:CA) had its target price updated by Stifel Nicolaus to $44.00 with a Buy…
Sage Group shares (LON: SGE) have been given a boost, with a new initiation of coverage seeing the…
Analyst Ratings (USA) American Airlines Group (AAL) had its target price raised to $12.00 by Barclays, maintaining an…
Analyst Ratings (USA) 3M (MMM) had its target raised by Barclays from $164.00 to $170.00, maintaining an Overweight…
Analyst Ratings (USA) American Airlines Group (AAL) had its target price raised to $12.00 by Barclays, maintaining an…
Analyst Ratings (USA) 3M (MMM) had its target raised by Barclays from $164.00 to $170.00, maintaining an Overweight…
Key Points AMD is jumping today after HSBC raised its rating on the stock from hold to buy.…
KNOXVILLE, Tenn. (WVLT) – Tennessee baseball coach Tony Vitello is set to join MLB Network draft coverage for…